Tudor Investment Corporation and Paul T. Jones II Schedule 13G Filing for scPharmaceuticals Inc.

Tudor Investment Corporation and Paul T. Jones II have filed a Schedule 13G with the SEC regarding their ownership of shares in scPharmaceuticals Inc. The filing indicates that as of the event date, the Reporting Persons may have been deemed to beneficially own more than 5% of the shares of Common Stock outstanding. However, the current ownership is reported as 0%. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement. The address of the business office of each of the Reporting Persons is 200 Elm Street, Stamford, CT 06901. The filing is certified to not be for the purpose of influencing the control of the issuer.